DMN:FRA
Diamyd Medical AB
€ ०.०६३
०.००%
(०.००) 1D
नोभेम्बर १९, ०८:०१:५२ GMT+१ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DMN...
Open
€ ०.०६
High
€ ०.०६
Low
€ ०.०६
Mkt. cap
१४.२२ करोड
Avg. vol.
०.००
Volume
०.००
52-wk high
€ १.८०
52-wk low
€ ०.०५
No. of employees
४२
Open
€ ०.०६
High
€ ०.०६
Low
€ ०.०६
Mkt. cap
१४.२२ करोड
Avg. vol.
०.००
Volume
०.००
52-wk high
€ १.८०
52-wk low
€ ०.०५
No. of employees
४२
News stories
From web sources and news partners
ChartMill
·
१५ मिनेट पहिले
S&P 500 Top Movers for Today's Session
24/7 Wall St.
·
२६ मिनेट पहिले
S&P 500 Drops Nearly 1% at Midday While the Dow Slides 1.5%
Investing.com
·
१ घण्टा पहिले
Record-negative dealer gamma and what it means for the S&P 500
Traders Union
·
२६ मिनेट पहिले
Charlie Bilello: S&P 500 declines 8% from October peak, largest pullback since March
Profile
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for type-1 diabetes. The company's investigational drug retogatein is based on a recombinant form of GAD₆₅, one of two human glutamate decarboxylase gene products.
The company is headquartered in Stockholm, and maintains a "biomanufacturing" facility in Umeå which utilizes bacuolavirus-mediated protein expression. Wikipedia
About Diamyd Medical AB